Daily Low-Dose Aspirin May Cut Pancreatic Cancer Risk
TUESDAY, Dec. 20, 2016 (HealthDay News) -- There's evidence that
daily low-dose aspirin may decrease the risk of pancreatic cancer,
according to a new study.
Ovarian Cancer Drug Given Fast-Track Approval
MONDAY, Dec. 19, 2016 (HealthDay News) -- The anti-cancer drug
Rubraca (rucaparib) has been granted accelerated approval by the
U.S. Food and Drug Administration to treat advanced ovarian
Chemo More Damaging to Hearts of Diabetics: Study
FRIDAY, Dec. 16, 2016 (HealthDay News) -- A small study finds
that cancer patients who have diabetes may suffer worse heart
damage from chemotherapy, potentially boosting their risk of heart
Minority Women Less Likely to Get Breast Cancer Screening
FRIDAY, Dec. 16, 2016 (HealthDay News) -- Black and Hispanic
women are less likely than white women to be screened for breast
cancer, a large review finds.
Angelina Jolie's Mastectomies Tied to Rise in Genetic Testing
THURSDAY, Dec. 15, 2016 (HealthDay News) -- After actress
Angelina Jolie had both breasts removed because she faced a
heightened risk for breast cancer, there was a spike in the number
of women who were tested for the genes that raise that risk. But,
there was no corresponding increase in mastectomy rates,
Many Early Colon Cancers Linked to Inherited Genes
THURSDAY, Dec. 15, 2016 (HealthDay News) -- As many as 1 in 6
colon cancer patients under the age of 50 has genetic traits that
greatly boost the risk of cancer, a new study finds.
Beating Breast Cancer But Still Paying a Price
THURSDAY, Dec. 15, 2016 (HealthDay News) -- Women who survive
breast cancer often experience lingering physical and emotional
symptoms that go untreated, new research suggests.
A Little Training Helps Couples Ease Into Skin Cancer Checks
WEDNESDAY, Dec. 14, 2016 (HealthDay News) -- Skin cancer checks
between couples don't have to be a puzzle -- or embarrassing, a new
Some Low-Income, Uninsured Patients Aren't Referred for Colonoscopy
TUESDAY, Dec. 13, 2016 (HealthDay News) -- Many low-income and
uninsured patients don't have a follow-up colonoscopy after
abnormal results on a colon cancer screening test -- even if
they're in a "safety net" health program, a new study finds.
Immune-Focused Drug Shows Promise Against Lung Cancer
TUESDAY, Dec. 13, 2016 (HealthDay News) -- An immunotherapy drug
called Tecentriq (atezolizumab) extended the survival of lung
cancer patients for several months longer than chemotherapy and
caused fewer side effects, according to a new study.